# Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer

> **NCT04298333** · PHASE1 · COMPLETED · sponsor: **Meabco A/S** · enrollment: 18 (actual)

## Conditions studied

- Metastatic Breast Cancer
- Stage IV Breast Cancer

## Interventions

- **DRUG:** BP-C1

## Key facts

- **NCT ID:** NCT04298333
- **Lead sponsor:** Meabco A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-27
- **Primary completion:** 2011-01-04
- **Final completion:** 2011-01-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04298333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04298333, "Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04298333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*